| Symbol |
Name |
|
AANAT
|
aralkylamine N-acetyltransferase
|
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
|
ABI1
|
abl-interactor 1
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5
|
|
ACSS2
|
acyl-CoA synthetase short-chain family member 2
|
|
ACVR1
|
activin A receptor, type I
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAM9
|
ADAM metallopeptidase domain 9
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGK
|
acylglycerol kinase
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AHSA1
|
AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALCAM
|
activated leukocyte cell adhesion molecule
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL4
|
angiopoietin-like 4
|
|
ANXA1
|
annexin A1
|
|
ANXA2
|
annexin A2
|
|
ANXA2R
|
annexin A2 receptor
|
|
APBA3
|
amyloid beta (A4) precursor protein-binding, family A, member 3
|
|
APC
|
adenomatous polyposis coli
|
|
APLN
|
apelin
|
|
APOA1
|
apolipoprotein A-I
|
|
APOE
|
apolipoprotein E
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AQP3
|
aquaporin 3 (Gill blood group)
|
|
AR
|
androgen receptor
|
|
ARF6
|
ADP-ribosylation factor 6
|
|
ARIH2
|
ariadne RBR E3 ubiquitin protein ligase 2
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
ARRB1
|
arrestin, beta 1
|
|
ASMT
|
acetylserotonin O-methyltransferase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP6AP2
|
ATPase, H+ transporting, lysosomal accessory protein 2
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
AXIN2
|
axin 2
|
|
B2M
|
beta-2-microglobulin
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCAR1
|
breast cancer anti-estrogen resistance 1
|
|
BCAR3
|
breast cancer anti-estrogen resistance 3
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGLAP
|
bone gamma-carboxyglutamate (gla) protein
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BMPR2
|
bone morphogenetic protein receptor, type II (serine/threonine kinase)
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BST1
|
bone marrow stromal cell antigen 1
|
|
BST2
|
bone marrow stromal cell antigen 2
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
C3
|
complement component 3
|
|
C3AR1
|
complement component 3a receptor 1
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C5AR1
|
complement component 5a receptor 1
|
|
CA2
|
carbonic anhydrase II
|
|
CALCR
|
calcitonin receptor
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CARD10
|
caspase recruitment domain family, member 10
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCDC88A
|
coiled-coil domain containing 88A
|
|
CCKBR
|
cholecystokinin B receptor
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL15
|
chemokine (C-C motif) ligand 15
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD14
|
CD14 molecule
|
|
CD164
|
CD164 molecule, sialomucin
|
|
CD200
|
CD200 molecule
|
|
CD200R1
|
CD200 receptor 1
|
|
CD209
|
CD209 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD2AP
|
CD2-associated protein
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD47
|
CD47 molecule
|
|
CD70
|
CD70 molecule
|
|
CD82
|
CD82 molecule
|
|
CD83
|
CD83 molecule
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC42
|
cell division cycle 42
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5
|
cyclin-dependent kinase 5
|
|
CDKL5
|
cyclin-dependent kinase-like 5
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN3
|
cyclin-dependent kinase inhibitor 3
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CEP55
|
centrosomal protein 55kDa
|
|
CEP57
|
centrosomal protein 57kDa
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLASP1
|
cytoplasmic linker associated protein 1
|
|
CLCNKA
|
chloride channel, voltage-sensitive Ka
|
|
CLEC2B
|
C-type lectin domain family 2, member B
|
|
CLU
|
clusterin
|
|
CMKLR1
|
chemerin chemokine-like receptor 1
|
|
COL11A1
|
collagen, type XI, alpha 1
|
|
COTL1
|
coactosin-like F-actin binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRHR1
|
corticotropin releasing hormone receptor 1
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRTC2
|
CREB regulated transcription coactivator 2
|
|
CRYAA
|
crystallin, alpha A
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSD
|
cathepsin D
|
|
CTSK
|
cathepsin K
|
|
CTSV
|
cathepsin V
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCN
|
decorin
|
|
DDHD1
|
DDHD domain containing 1
|
|
DDR1
|
discoidin domain receptor tyrosine kinase 1
|
|
DEFB103B
|
defensin, beta 103B
|
|
DEPDC1B
|
DEP domain containing 1B
|
|
DESI2
|
desumoylating isopeptidase 2
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIAPH3
|
diaphanous-related formin 3
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DMBT1
|
deleted in malignant brain tumors 1
|
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYSL2
|
dihydropyrimidinase-like 2
|
|
DUSP1
|
dual specificity phosphatase 1
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F3
|
E2F transcription factor 3
|
|
EDIL3
|
EGF-like repeats and discoidin I-like domains 3
|
|
EDN1
|
endothelin 1
|
|
EDN3
|
endothelin 3
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2
|
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGLN1
|
egl-9 family hypoxia-inducible factor 1
|
|
EGLN3
|
egl-9 family hypoxia-inducible factor 3
|
|
EGR1
|
early growth response 1
|
|
EGR4
|
early growth response 4
|
|
EIF3M
|
eukaryotic translation initiation factor 3, subunit M
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
ELF4
|
E74-like factor 4 (ets domain transcription factor)
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
ENTPD1
|
ectonucleoside triphosphate diphosphohydrolase 1
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHB2
|
EPH receptor B2
|
|
EPHB4
|
EPH receptor B4
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRA
|
estrogen-related receptor alpha
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV4
|
ets variant 4
|
|
EYA2
|
EYA transcriptional coactivator and phosphatase 2
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
FASN
|
fatty acid synthase
|
|
FBXO11
|
F-box protein 11
|
|
FBXO5
|
F-box protein 5
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FBXW8
|
F-box and WD repeat domain containing 8
|
|
FERMT3
|
fermitin family member 3
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLNB
|
filamin B, beta
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL1
|
FOS-like antigen 1
|
|
FOXA2
|
forkhead box A2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FRS3
|
fibroblast growth factor receptor substrate 3
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FZD8
|
frizzled class receptor 8
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GABRP
|
gamma-aminobutyric acid (GABA) A receptor, pi
|
|
GAL
|
galanin/GMAP prepropeptide
|
|
GALR1
|
galanin receptor 1
|
|
GAS6
|
growth arrest-specific 6
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GATA3
|
GATA binding protein 3
|
|
GCHFR
|
GTP cyclohydrolase I feedback regulator
|
|
GCLM
|
glutamate-cysteine ligase, modifier subunit
|
|
GDF2
|
growth differentiation factor 2
|
|
GH1
|
growth hormone 1
|
|
GH2
|
growth hormone 2
|
|
GHR
|
growth hormone receptor
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLP1R
|
glucagon-like peptide 1 receptor
|
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2
|
|
GMCL1
|
germ cell-less, spermatogenesis associated 1
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNB2L1
|
guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1
|
|
GP6
|
glycoprotein VI (platelet)
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GPR55
|
G protein-coupled receptor 55
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H19
|
H19, imprinted maternally expressed transcript (non-protein coding)
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HAVCR1
|
hepatitis A virus cellular receptor 1
|
|
HBB
|
hemoglobin, beta
|
|
HBEGF
|
heparin-binding EGF-like growth factor
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC7
|
histone deacetylase 7
|
|
HES1
|
hes family bHLH transcription factor 1
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIF1AN
|
hypoxia inducible factor 1, alpha subunit inhibitor
|
|
HIPK2
|
homeodomain interacting protein kinase 2
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMMR
|
hyaluronan-mediated motility receptor (RHAMM)
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HOXA10
|
homeobox A10
|
|
HOXB7
|
homeobox B7
|
|
HPSE
|
heparanase
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA14
|
heat shock 70kDa protein 14
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID1
|
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein
|
|
ID3
|
inhibitor of DNA binding 3, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL19
|
interleukin 19
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL33R
|
interleukin 33 receptor
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9
|
interleukin 9
|
|
ILK
|
integrin-linked kinase
|
|
INHBB
|
inhibin, beta B
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IQSEC1
|
IQ motif and Sec7 domain 1
|
|
IRF1
|
interferon regulatory factor 1
|
|
ISCU
|
iron-sulfur cluster assembly enzyme
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITCH
|
itchy E3 ubiquitin protein ligase
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITPR1
|
inositol 1,4,5-trisphosphate receptor, type 1
|
|
ITPR2
|
inositol 1,4,5-trisphosphate receptor, type 2
|
|
ITPR3
|
inositol 1,4,5-trisphosphate receptor, type 3
|
|
JAG1
|
jagged 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KCNN3
|
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3
|
|
KDM6B
|
lysine (K)-specific demethylase 6B
|
|
KDR
|
kinase insert domain receptor
|
|
KEAP1
|
kelch-like ECH-associated protein 1
|
|
KIF3A
|
kinesin family member 3A
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KL
|
klotho
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF5
|
Kruppel-like factor 5 (intestinal)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRF1
|
killer cell lectin-like receptor subfamily F, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAIR2
|
leukocyte-associated immunoglobulin-like receptor 2
|
|
LAT
|
linker for activation of T cells
|
|
LATS2
|
large tumor suppressor kinase 2
|
|
LCN2
|
lipocalin 2
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS3BP
|
lectin, galactoside-binding, soluble, 3 binding protein
|
|
LHX6
|
LIM homeobox 6
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIN28A
|
lin-28 homolog A (C. elegans)
|
|
LIN28B
|
lin-28 homolog B (C. elegans)
|
|
LIPH
|
lipase, member H
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LPL
|
lipoprotein lipase
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LRP5
|
low density lipoprotein receptor-related protein 5
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)
|
|
MAP1LC3B
|
microtubule-associated protein 1 light chain 3 beta
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K11
|
mitogen-activated protein kinase kinase kinase 11
|
|
MAP3K12
|
mitogen-activated protein kinase kinase kinase 12
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPKAP1
|
mitogen-activated protein kinase associated protein 1
|
|
MAPT
|
microtubule-associated protein tau
|
|
MAS1
|
MAS1 proto-oncogene, G protein-coupled receptor
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
|
MB
|
myoglobin
|
|
MC2R
|
melanocortin 2 receptor (adrenocorticotropic hormone)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MED1
|
mediator complex subunit 1
|
|
MEP1B
|
meprin A, beta
|
|
MEPE
|
matrix extracellular phosphoglycoprotein
|
|
MERTK
|
MER proto-oncogene, tyrosine kinase
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MID1
|
midline 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR1-1
|
microRNA 1-1
|
|
MIR101-1
|
microRNA 101-1
|
|
MIR10B
|
microRNA 10b
|
|
MIR124-1
|
microRNA 124-1
|
|
MIR126
|
microRNA 126
|
|
MIR128-1
|
microRNA 128-1
|
|
MIR129-2
|
microRNA 129-2
|
|
MIR130A
|
microRNA 130a
|
|
MIR130B
|
microRNA 130b
|
|
MIR132
|
microRNA 132
|
|
MIR140
|
microRNA 140
|
|
MIR141
|
microRNA 141
|
|
MIR148B
|
microRNA 148b
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR15A
|
microRNA 15a
|
|
MIR17HG
|
miR-17-92 cluster host gene
|
|
MIR185
|
microRNA 185
|
|
MIR187
|
microRNA 187
|
|
MIR193A
|
microRNA 193a
|
|
MIR195
|
microRNA 195
|
|
MIR196B
|
microRNA 196b
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR204
|
microRNA 204
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR212
|
microRNA 212
|
|
MIR214
|
microRNA 214
|
|
MIR217
|
microRNA 217
|
|
MIR218-1
|
microRNA 218-1
|
|
MIR218-2
|
microRNA 218-2
|
|
MIR221
|
microRNA 221
|
|
MIR223
|
microRNA 223
|
|
MIR224
|
microRNA 224
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR2909
|
microRNA 2909
|
|
MIR296
|
microRNA 296
|
|
MIR30A
|
microRNA 30a
|
|
MIR320A
|
microRNA 320a
|
|
MIR335
|
microRNA 335
|
|
MIR34A
|
microRNA 34a
|
|
MIR376C
|
microRNA 376c
|
|
MIR429
|
microRNA 429
|
|
MIR451A
|
microRNA 451a
|
|
MIR494
|
microRNA 494
|
|
MIR506
|
microRNA 506
|
|
MIR577
|
microRNA 577
|
|
MIR675
|
microRNA 675
|
|
MIR93
|
microRNA 93
|
|
MIR96
|
microRNA 96
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKL2
|
MKL/myocardin-like 2
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MKRN3
|
makorin ring finger protein 3
|
|
MLXIP
|
MLX interacting protein
|
|
MMD
|
monocyte to macrophage differentiation-associated
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOG
|
myelin oligodendrocyte glycoprotein
|
|
MORC2
|
MORC family CW-type zinc finger 2
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MRPL13
|
mitochondrial ribosomal protein L13
|
|
MS4A2
|
membrane-spanning 4-domains, subfamily A, member 2
|
|
MSLN
|
mesothelin
|
|
MTNR1A
|
melatonin receptor 1A
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYLIP
|
myosin regulatory light chain interacting protein
|
|
MYLK2
|
myosin light chain kinase 2
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NANOG
|
Nanog homeobox
|
|
NBN
|
nibrin
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NCR3
|
natural cytotoxicity triggering receptor 3
|
|
NDC80
|
NDC80 kinetochore complex component
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NEDD9
|
neural precursor cell expressed, developmentally down-regulated 9
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFIA
|
nuclear factor I/A
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
|
NMU
|
neuromedin U
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NOX4
|
NADPH oxidase 4
|
|
NPS
|
neuropeptide S
|
|
NPY
|
neuropeptide Y
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1H3
|
nuclear receptor subfamily 1, group H, member 3
|
|
NR2C2
|
nuclear receptor subfamily 2, group C, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A2
|
nuclear receptor subfamily 4, group A, member 2
|
|
NRG1
|
neuregulin 1
|
|
NRG3
|
neuregulin 3
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NSMF
|
NMDA receptor synaptonuclear signaling and neuronal migration factor
|
|
NTF4
|
neurotrophin 4
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
NUMB
|
numb homolog (Drosophila)
|
|
NUPR1
|
nuclear protein, transcriptional regulator, 1
|
|
NXPH1
|
neurexophilin 1
|
|
OGFR
|
opioid growth factor receptor
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OPTN
|
optineurin
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
OXTR
|
oxytocin receptor
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PACS2
|
phosphofurin acidic cluster sorting protein 2
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PARP9
|
poly (ADP-ribose) polymerase family, member 9
|
|
PAX6
|
paired box 6
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCDH10
|
protocadherin 10
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFD
|
platelet derived growth factor D
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1
|
|
PDLIM2
|
PDZ and LIM domain 2 (mystique)
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PELP1
|
proline, glutamate and leucine rich protein 1
|
|
PGR
|
progesterone receptor
|
|
PHEX
|
phosphate regulating endopeptidase homolog, X-linked
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIN1
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLK1
|
polo-like kinase 1
|
|
PLK3
|
polo-like kinase 3
|
|
PLSCR1
|
phospholipid scramblase 1
|
|
PLXNB1
|
plexin B1
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
POMC
|
proopiomelanocortin
|
|
PON1
|
paraoxonase 1
|
|
POU3F2
|
POU class 3 homeobox 2
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARD
|
peroxisome proliferator-activated receptor delta
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP1CC
|
protein phosphatase 1, catalytic subunit, gamma isozyme
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PPY
|
pancreatic polypeptide
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRDX4
|
peroxiredoxin 4
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKCI
|
protein kinase C, iota
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PRL
|
prolactin
|
|
PROK2
|
prokineticin 2
|
|
PROKR2
|
prokineticin receptor 2
|
|
PSAP
|
prosaposin
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK7
|
protein tyrosine kinase 7 (inactive)
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PXN
|
paxillin
|
|
PYY
|
peptide YY
|
|
RAB5A
|
RAB5A, member RAS oncogene family
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2
|
|
RB1
|
retinoblastoma 1
|
|
RBBP8
|
retinoblastoma binding protein 8
|
|
RBM7
|
RNA binding motif protein 7
|
|
RECK
|
reversion-inducing-cysteine-rich protein with kazal motifs
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
REST
|
RE1-silencing transcription factor
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RHOA
|
ras homolog family member A
|
|
RHOD
|
ras homolog family member D
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
ROBO1
|
roundabout, axon guidance receptor, homolog 1 (Drosophila)
|
|
ROCK1
|
Rho-associated, coiled-coil containing protein kinase 1
|
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2
|
|
RPS27
|
ribosomal protein S27
|
|
RPS6KA3
|
ribosomal protein S6 kinase, 90kDa, polypeptide 3
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
S100A2
|
S100 calcium binding protein A2
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
S1PR3
|
sphingosine-1-phosphate receptor 3
|
|
SATB1
|
SATB homeobox 1
|
|
SCAP
|
SREBF chaperone
|
|
SCRIB
|
scribbled planar cell polarity protein
|
|
SDC1
|
syndecan 1
|
|
SEMA4D
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D
|
|
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFN
|
stratifin
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHH
|
sonic hedgehog
|
|
SIAH2
|
siah E3 ubiquitin protein ligase 2
|
|
SIGLEC14
|
sialic acid binding Ig-like lectin 14
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SIRT1
|
sirtuin 1
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A6
|
solute carrier family 12 (potassium/chloride transporter), member 6
|
|
SLC16A10
|
solute carrier family 16 (aromatic amino acid transporter), member 10
|
|
SLC37A4
|
solute carrier family 37 (glucose-6-phosphate transporter), member 4
|
|
SLC40A1
|
solute carrier family 40 (iron-regulated transporter), member 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD1
|
SMAD family member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SOX3
|
SRY (sex determining region Y)-box 3
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPOP
|
speckle-type POZ protein
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SQSTM1
|
sequestosome 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
SRXN1
|
sulfiredoxin 1
|
|
SST
|
somatostatin
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
ST2
|
suppression of tumorigenicity 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK11
|
serine/threonine kinase 11
|
|
STK38
|
serine/threonine kinase 38
|
|
STK38L
|
serine/threonine kinase 38 like
|
|
STK39
|
serine threonine kinase 39
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAC3
|
tachykinin 3
|
|
TACR3
|
tachykinin receptor 3
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TBX1
|
T-box 1
|
|
TBX21
|
T-box 21
|
|
TCF3
|
transcription factor 3
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TERT
|
telomerase reverse transcriptase
|
|
TF
|
transferrin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TGM2
|
transglutaminase 2
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THYN1
|
thymocyte nuclear protein 1
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TICAM1
|
toll-like receptor adaptor molecule 1
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TNFSF15
|
tumor necrosis factor (ligand) superfamily, member 15
|
|
TOPBP1
|
topoisomerase (DNA) II binding protein 1
|
|
TP53
|
tumor protein p53
|
|
TP53INP1
|
tumor protein p53 inducible nuclear protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPD52
|
tumor protein D52
|
|
TPH1
|
tryptophan hydroxylase 1
|
|
TRIB2
|
tribbles pseudokinase 2
|
|
TRIO
|
trio Rho guanine nucleotide exchange factor
|
|
TRIP12
|
thyroid hormone receptor interactor 12
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSGA10
|
testis specific, 10
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TTC8
|
tetratricopeptide repeat domain 8
|
|
TTK
|
TTK protein kinase
|
|
TUFM
|
Tu translation elongation factor, mitochondrial
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UBE2I
|
ubiquitin-conjugating enzyme E2I
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
USP1
|
ubiquitin specific peptidase 1
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VAV2
|
vav 2 guanine nucleotide exchange factor
|
|
VAV3
|
vav 3 guanine nucleotide exchange factor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VIPR2
|
vasoactive intestinal peptide receptor 2
|
|
VLDLR
|
very low density lipoprotein receptor
|
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1
|
|
WNT1
|
wingless-type MMTV integration site family, member 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WT1
|
Wilms tumor 1
|
|
WTAP
|
Wilms tumor 1 associated protein
|
|
WWC1
|
WW and C2 domain containing 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XPO1
|
exportin 1
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
YAP1
|
Yes-associated protein 1
|
|
YY1
|
YY1 transcription factor
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZEB2
|
zinc finger E-box binding homeobox 2
|
|
ZNF396
|
zinc finger protein 396
|
|
ZYX
|
zyxin
|
